BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11514007)

  • 1. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.
    Hellebust TP; Dale E; Skjønsberg A; Olsen DR
    Radiother Oncol; 2001 Sep; 60(3):273-80. PubMed ID: 11514007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
    Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer.
    Al-Halabi H; Portelance L; Duclos M; Reniers B; Bahoric B; Souhami L
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1092-7. PubMed ID: 19879059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
    Wachter-Gerstner N; Wachter S; Reinstadler E; Fellner C; Knocke TH; Wambersie A; Pötter R
    Radiother Oncol; 2003 Sep; 68(3):269-76. PubMed ID: 13129634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer.
    Saarnak AE; Boersma M; van Bunningen BN; Wolterink R; Steggerda MJ
    Radiother Oncol; 2000 Jul; 56(1):37-42. PubMed ID: 10869753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK; Caldwell K; Lau A; Fowler AR
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms.
    Kim RY; Pareek P
    Brachytherapy; 2003; 2(4):200-6. PubMed ID: 15062127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
    Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning.
    Wang B; Kwon A; Zhu Y; Yeo I; Henson CF
    Brachytherapy; 2009; 8(2):240-247. PubMed ID: 19230789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should the organs at risk be contoured in vaginal cuff brachytherapy?
    Holloway CL; Macklin EA; Cormack RA; Viswanathan AN
    Brachytherapy; 2011; 10(4):313-7. PubMed ID: 21193355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy dose received by bladder and rectum in patients with inoperable cervical cancer: CT-based 3D view.
    Marošević G; Osmić H; Fazlić S; Mileusnić D; Babić J
    Acta Med Acad; 2013; 42(1):83-4. PubMed ID: 23735071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.